Pretreatment cytogenetics and clinical responses
| Cytogenetic characteristic . | No. (%) . | Response no. (%) . |
|---|---|---|
| +8 | 1 (2) | 0 (0) |
| −5/−7 | 8 (15) | 5 (62) |
| Diploid | 18 (34) | 7 (39) |
| Insufficient metaphases | 2 (4) | 1 (50) |
| Miscellaneous | 21 (40) | 7 (33) |
| t(8;21) | 1 (2) | 0 (0) |
| −y | 2 (4) | 0 (0) |
| Cytogenetic response* | 11 | 4 (36) |
| Cytogenetic characteristic . | No. (%) . | Response no. (%) . |
|---|---|---|
| +8 | 1 (2) | 0 (0) |
| −5/−7 | 8 (15) | 5 (62) |
| Diploid | 18 (34) | 7 (39) |
| Insufficient metaphases | 2 (4) | 1 (50) |
| Miscellaneous | 21 (40) | 7 (33) |
| t(8;21) | 1 (2) | 0 (0) |
| −y | 2 (4) | 0 (0) |
| Cytogenetic response* | 11 | 4 (36) |
Patients with evaluable metaphases.